Critical illness myopathy and GLUT4 significance of insulin and muscle contraction

American Journal of Respiratory and Critical Care Medicine

Volumn 187, Issue 4, 2013, Pages 387-396

  Weber Carstens, Steffen ^a   Schneider, Joanna ^b   Wollersheim, Tobias ^a   Assmann, Anke ^c   Bierbrauer, Jeffrey ^a   Marg, Andreas ^b   Hasani, Hadi Al ^d   Chadt, Alexandra ^d   Wenzel, Katrin ^b   Koch, Susanne ^a   Fielitz, Jens ^b   Kleber, Christian ^c   Faust, Katharina ^a   Mai, Knut ^c   Spies, Claudia D ^a   Luft, Friedrich C ^b   Boschmann, Michael ^b   Spranger, Joachim ^c   Spuler, Simone ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c Department of Endocrinology ^*  (Germany)

^d HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE TRANSPORTER 4; INSULIN; MESSENGER RNA;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; CRITICAL ILLNESS MYOPATHY; ELECTROSTIMULATION; FEMALE; GLUCOSE METABOLISM; HOSPITALIZATION; HUMAN; INSULIN SENSITIVITY; INTENSIVE CARE UNIT; MALE; MULTIPLE ORGAN FAILURE; MUSCLE BIOPSY; MUSCLE CONTRACTION; MUSCLE EXCITATION; MYOPATHY; OBSERVATIONAL STUDY; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEPSIS; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

ADULT; AGED; ANALYSIS OF VARIANCE; BIOPSY; CRITICAL ILLNESS; ELECTRIC STIMULATION; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TRANSPORTER TYPE 4; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MICRODIALYSIS; MIDDLE AGED; MUSCLE CONTRACTION; MUSCULAR DISEASES; ORGAN DYSFUNCTION SCORES; PILOT PROJECTS; PROSPECTIVE STUDIES; RESPIRATION, ARTIFICIAL; SEPSIS; SIGNAL TRANSDUCTION;

EID: 84873944277     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201209-1649OC     Document Type: Article

References (44)

1. Schweickert WD, Hall J. ICU-acquired weakness. Chest 2007;131:1541-1549.
2. De Jonghe B. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA 2002;288:2859-2867.
3. Herridge MS, Tansey CM, Matté A, Tomlinson G, Diaz-Granados N, Cooper A, Guest CB, Mazer CD, Mehta S, Stewart TE, et al. Canadian Critical Care Trials Group. Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med 2011;364:1293-1304.
4. Weber-Carstens S, Koch S, Spuler S, Spies CD, Bubser F, Wernecke KD, Deja M. Nonexcitable muscle membrane predicts intensive care unitacquired paresis in mechanically ventilated, sedated patients. Crit Care Med 2009;37:2632-2637.
5. Puthucheary Z, Rawal J, Ratnayake G, Harridge S, Montgomery H, Hart N. Neuromuscular blockade and skeletal muscle weakness in critically ill patients: time to rethink the evidence? Am J Respir Crit Care Med 2012;185:911-917.
6. Bierbrauer J, Koch S, Olbricht C, Hamati J, Lodka D, Schneider J, Luther-Schröder A, Kleber C, Faust K, Wiesener S, et al. Early type II fiber atrophy in intensive care unit patients with nonexcitable muscle membrane. Crit Care Med 2012;40:647-650.
7. Gutmann L, Blumenthal D, Schochet SS. Acute type II myofiber atrophy in critical illness. Neurology 1996;46:819-821.
8. Helliwell TR, Wilkinson A, Griffiths RD, McClelland P, Palmer TE, Bone JM. Muscle fibre atrophy in critically ill patients is associated with the loss of myosin filaments and the presence of lysosomal enzymes and ubiquitin. Neuropathol Appl Neurobiol 1998;24:507-517.
9. Latronico N, Bolton CF. Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis. Lancet Neurol 2011; 10:931-941.
10. Morris PE, Goad A, Thompson C, Taylor K, Harry B, Passmore L, Ross A, Anderson L, Baker S, Sanchez M, et al. Early intensive care unit mobility therapy in the treatment of acute respiratory failure. Crit Care Med 2008;36:2238-2243.
11. Schweickert WD, Pohlman MC, Pohlman AS, Nigos C, Pawlik AJ, Esbrook CL, Spears L, Miller M, Franczyk M, Deprizio D, et al. Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial. Lancet 2009;373:1874-1882.
12. Weber-Carstens S, Deja M, Koch S, Spranger J, Bubser F, Wernecke KD, Spies CD, Spuler S, Keh D. Risk factors in critical illness myopathy during the early course of critical illness: a prospective observational study. Crit Care 2010;14:R119.
13. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345:1359-1367.
14. Hermans G, Wilmer A, Meersseman W, Milants I, Wouters PJ, Bobbaers H, Bruyninckx F, Van den Berghe G. Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit. Am J Respir Crit Care Med 2007;175:480-489.
15. Derde S, Hermans G, Derese I, Güiza F, Hedström Y, Wouters PJ, Bruyninckx F, D'Hoore A, Larsson L, Van den Berghe G, et al. Muscle atrophy and preferential loss of myosin in prolonged critically ill patients. Crit Care Med 2012;40:79-89.
16. Zisman A, Peroni OD, Abel ED, Michael MD, Mauvais-Jarvis F, Lowell BB, Wojtaszewski JF, Hirshman MF, Virkamaki A, Goodyear LJ, et al. Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. Nat Med 2000;6: 924-928.
17. Stöckli J, Fazakerley DJ, Coster AC, Holman GD, James DE. Muscling in on GLUT4 kinetics. Commun Integr Biol 2010;3:260-262.
18. Douen AG, Ramlal T, Klip A, Young DA, Cartee GD, Holloszy JO. Exercise-induced increase in glucose transporters in plasma membranes of rat skeletal muscle. Endocrinology 1989;124:449-454.
19. James DE, Brown R, Navarro J, Pilch PF. Insulin-regulatable tissues express a unique insulin-sensitive glucose transport protein. Nature 1988; 333:183-185.
20. Lund S, Holman GD, Schmitz O, Pedersen O. Contraction stimulates translocation of glucose transporter GLUT4 in skeletal muscle through a mechanism distinct from that of insulin. Proc Natl Acad Sci USA 1995; 92:5817-5821.
21. Herman MA, Kahn BB. Glucose transport and sensing in the maintenance of glucose homeostasis and metabolic harmony. J Clin Invest 2006;116:1767-1775.
22. Kurth-Kraczek EJ, Hirshman MF, Goodyear LJ, Winder WW. 59 AMPactivated protein kinase activation causes GLUT4 translocation in skeletal muscle. Diabetes 1999;48:1667-1671.
23. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, et al., International Surviving Sepsis Campaign Guidelines Committee, American Association of Critical-Care Nurses, American College of Chest Physicians, American College of Emergency Physicians, Canadian Critical Care Society, European Society of Clinical Microbiology and Infectious Diseases, European Society of Intensive Care Medicine, European Respiratory Society, International Sepsis Forum, Japanese Association for Acute Medicine, Japanese Society of Intensive Care Medicine, Society of Critical Care Medicine, Society of Hospital Medicine, Surgical Infection Society, World Federation of Societies of Intensive and Critical Care Medicine. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008;36:296-327.
24. Martin J, Heymann A, Bäsell K, Baron R, Biniek R, Bürkle H, Dall P, Dictus C, Eggers V, Eichler I, et al. Evidence and consensus-based german guidelines for the management of analgesia, sedation and delirium in intensive care: short version. Ger Med Sci 2010;8: Doc02.
25. Kreymann KG, BergerMM,Deutz NE, Hiesmayr M, Jolliet P, KazandjievG, Nitenberg G, van den Berghe G, Wernerman J. DGEM (German Society for Nutritional Medicine), Ebner C, Hartl W, Heymann C, Spies C, ESPEN (European Society for Parenteral and Enteral Nutrition). ESPEN guidelines on enteral nutrition: intensive care. Clin Nutr 2006; 25:210-223.
26. Mai K, Andres J, Biedasek K, Weicht J, Bobbert T, Sabath M, Meinus S, Reinecke F, Möhlig M, Weickert MO, et al. Free fatty acids link metabolism and regulation of the insulin-sensitizing fibroblast growth factor-21. Diabetes 2009;58:1532-1538.
27. Boschmann M, Engeli S, Moro C, Luedtke A, Adams F, Gorzelniak K, Rahn G, Mähler A, Dobberstein K, Krüger A, et al. LMNA mutations, skeletal muscle lipid metabolism, and insulin resistance. J Clin Endocrinol Metab 2010;95:1634-1643.
28. Rich MM, Teener JW, Raps EC, Schotland DL, Bird SJ. Muscle is electrically inexcitable in acute quadriplegic myopathy. Neurology 1996;46:731-736.
29. Jäger S, Handschin C, St-Pierre J, Spiegelman BM. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of pgc-1alpha. Proc Natl Acad Sci USA 2007;104:12017-12022.
30. Lauritzen HP, Galbo H, Toyoda T, Goodyear LJ. Kinetics of contractioninduced GLUT4 translocation in skeletal muscle fibers from living mice. Diabetes 2010;59:2134-2144.
31. Foley K, Boguslavsky S, Klip A. Endocytosis, recycling, and regulated exocytosis of glucose transporter 4. Biochemistry 2011;50: 3048-3061.
32. Fahy BG, Sheehy AM, Coursin DB. Glucose control in the intensive care unit. Crit Care Med 2009;37:1769-1776.
33. Agwunobi AO, Reid C, Maycock P, Little RA, Carlson GL. Insulin resistance and substrate utilization in human endotoxemia. J Clin Endocrinol Metab 2000;85:3770-3778.
34. Zauner A, Nimmerrichter P, Anderwald C, Bischof M, Schiefermeier M, Ratheiser K, Schneeweiss B, Zauner C. Severity of insulin resistance in critically ill medical patients. Metabolism 2007;56:1-5.
35. Goodyear LJ, Kahn BB. Exercise, glucose transport, and insulin sensitivity. Annu Rev Med 1998;49:235-261.
36. Avruch J. Insulin signal transduction through protein kinase cascades. Mol Cell Biochem 1998;182:31-48.
37. Thompson LH, Kim HT, Ma Y, Kokorina NA, Messina JL. Acute, muscle-type specific insulin resistance following injury. Mol Med 2008;14:715-723.
38. Wada T, Sasaoka T, Funaki M, Hori H, Murakami S, Ishiki M, Haruta T, Asano T, Ogawa W, Ishihara H, et al. Overexpression of sh2- containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 59- phosphatase catalytic activity. Mol Cell Biol 2001;21:1633-1646.
39. Hardie DG, Ross FA, Hawley SA. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat RevMol Cell Biol 2012;13:251-262.
40. Winder WW, Hardie DG. Inactivation of acetyl-coa carboxylase and activation of amp-activated protein kinase in muscle during exercise. Am J Physiol 1996;270:E299-E304.
41. O'Neill HM, Maarbjerg SJ, Crane JD, Jeppesen J, Jørgensen SB, Schertzer JD, Shyroka O, Kiens B, van Denderen BJ, Tarnopolsky MA, et al. AMP-activated protein kinase (AMPK) beta1beta2 muscle null mice reveal an essential role for AMPK in maintaining mitochondrial content and glucose uptake during exercise. Proc Natl Acad Sci USA 2011;108:16092-16097.
42. Gwinn DM, Shackelford DB, Egan DF, Mihaylova MM, Mery A, Vasquez DS, Turk BE, Shaw RJ. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell 2008;30:214-226.
43. Ikematsu N, Dallas ML, Ross FA, Lewis RW, Rafferty JN, David JA, Suman R, Peers C, Hardie GD, Evans M. Phosphorylation of the voltage-gated potassium channel kv2.1 by amp-activated protein kinase regulates membrane excitability. Proc Natl Acad Sci USA 2011; 108:18132-18137.
44. Herman MA, Peroni OD, Villoria J, Schön MR, Abumrad NA, Blüher M, Klein S, Kahn BB. A novel chrebp isoform in adipose tissue regulates systemic glucose metabolism. Nature 2012;484:333-338.